Mark Mercola

NIH Rank #771

NIH Funding · FY2024

Total Funding

$6.2M

Fiscal year 2024

Grants Awarded

Active NIH grants

National Rank

#771

Among 57,894 PIs

First NIH Award

2024

Year of first funding

NIH funding totals and national rank by fiscal year.

Single fiscal year on record (FY2024): $6.2M across 11 grants · National rank #771.

Mark Mercola's NIH grant portfolio, ranked by award amount.

2R01HL130020-09A1R01
Elucidating Mechanism of Cardiac Fibrosis with Cell Village of Pooled Human iPSCs
Stanford University
$776K
award amount
1R01HL171102-01R01
Modeling Susceptibility to Radiation Therapy-induced Cardiotoxicity Using Cell Village iPSCs
Stanford University
$697.9K
award amount
5R01HL146690-06R01
Human iPSC Model to Elucidate Metabolic Interplay in Diabetic Cardimyopathy
Stanford University
$672.7K
award amount
2R01HL130840-05R01
MicroRNA Control of Dilated Cardiomyopathy
Stanford University
$665.7K
award amount
2P01HL141084-06P01
Multiscale Systems to Elucidate Susceptibility and Cardioprotective Mechanisms in Cardio-oncology
Stanford University
$626.1K
award amount
1R01HL170080-01A1R01
Evaluation of the AMPK-BACH1-NRF2 Axis as a Therapeutic Target for Inherited DCM
Stanford University
$602.1K
award amount
5R01HL145676-06R01
Single-cell Multi-omic Profiling of Drug Responses Using Pooled iPSC-CM Differentiation
Stanford University
$597.1K
award amount
5R01HL152055-04R01
Targeting the genotype to phenotype link in HCM as a therapeutic strategy
Stanford University
$569.3K
award amount
5R01HL169340-02R01
hiPSC Modeling of Restrictive Cardiomyopathy for Drug Testing
Stanford University
$560.4K
award amount
5R33HL167258-02R33
High throughput platform for simultaneous multiparametric assessment of cardiac physiology for heart failure drug development
Stanford University
$444.8K
award amount